MEN1 connects transcription factors and epigenetic effectors, contributing to its function as an oncogenic tumor promoter in KMT2Ar AL, NPM1m AML, and other rare AL subtypes associated with poor outcomes [60]. Here, MEN1 is linked to acute myeloid leukemia.